Ibrutinib is a type of cancer medication called a kinase inhibitor. Ibrutinib helps to slow down how quickly certain blood cancers progresses by working against cancerous B cells, a type of white blood cell. It does this by blocking Bruton's tyrosine kinase (BTK) signaling. BTK is a protein found on B cells that instructs B cells to remain alive and multiple. More info »
Rimanendo sul nostro sito accetti automaticamente la memorizzazione e l'elaborazione dei tuoi dati personali, in conformità con la nostra Informativa sulla privacy.
Denmark
Finland
Norway
Sweden